Spectral Medical Inc. Announces Pricing of Previously Announced Offering
October 06, 2022 17:00 ET
|
Spectral Medical Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (TSX: EDT) (“Spectral” or the...
Spectral Medical Inc. Announces Proposed Public Offering of Units and Private Placement of Notes
October 05, 2022 16:26 ET
|
Spectral Medical Inc.
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (TSX: EDT) (“Spectral” or the...
Spectral Medical Provides Update on Tigris Clinical Trial
October 04, 2022 09:21 ET
|
Spectral Medical Inc.
Robust recruitment activities experienced in closing weeks of September44 patients now enrolled TORONTO, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX:...
Spectral Announces FDA Approval to Add Up to 10 Additional Tigris Clinical Trial Sites
August 18, 2022 08:00 ET
|
Spectral Medical Inc.
TORONTO, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Announces Second Quarter Results and Provides Corporate Update
August 12, 2022 08:00 ET
|
Spectral Medical Inc.
TORONTO, Aug. 12, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Announces that its Wholly-Owned Subsidiary Dialco Medical and Distribution Partner Marathon Medical Awarded Contract to Provide SAMI Dialysis Devices to the US Department of Veterans Affairs
August 08, 2022 08:00 ET
|
Spectral Medical Inc.
TORONTO, Aug. 08, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical’s Chief Medical Officer, Dr. John Kellum, to be the Featured Speaker in Webinar Hosted by Sepsis Alliance
July 26, 2022 08:00 ET
|
Spectral Medical Inc.
TORONTO, July 26, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical Provides Update on Tigris Clinical Trial
July 20, 2022 08:00 ET
|
Spectral Medical Inc.
Provides positive case study on patient enrolled at University of Michigan 14 clinical sites actively enrolling patients with 40 patients now randomized TORONTO, July 20, 2022 (GLOBE NEWSWIRE) --...
Spectral Medical Highlights From Vicenza Course 2022
July 14, 2022 10:00 ET
|
Spectral Medical Inc.
TORONTO, July 14, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...
Spectral Medical to Participate at the Benzinga All Access event on July 15, 2022
July 13, 2022 08:00 ET
|
Spectral Medical Inc.
TORONTO, July 13, 2022 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock,...